PAAMCP
BIIB icon

Pacific Alternative Asset Management Company (PAAMCO)’s Biogen BIIB Stock Holding History

Pacific Alternative Asset Management Company (PAAMCO)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6,000
Closed -$2.53M – 45
2015
Q1 		$2.53M Buy
+6,000
New +$2.36M 0.69% 42

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pacific Alternative Asset Management Company (PAAMCO)'s BIIB Position: Q4 2014 in Review

Pacific Alternative Asset Management Company (PAAMCO) sold out of Biogen (BIIB) in Q4 2014, closing a stake of 8,974 shares — an estimated $2.9M sold.

Pacific Alternative Asset Management Company (PAAMCO) first reported a position in BIIB in Q4 2013 and held it in 4 quarters. The position peaked at $3.64M in Q2 2014. 885 funds tracked by Wall St. Rank hold BIIB as of Q4 2014.

  • Pacific Alternative Asset Management Company (PAAMCO) reported no remaining Biogen position as of Q4 2014 after selling out during the quarter.
  • Pacific Alternative Asset Management Company (PAAMCO) sold 8,974 Biogen shares in Q4 2014, an estimated $2.9M.
  • Pacific Alternative Asset Management Company (PAAMCO) first reported a position in Biogen in Q4 2013 and held it in 4 quarters.
  • Pacific Alternative Asset Management Company (PAAMCO)'s Biogen position peaked at $3.64M in Q2 2014.
  • 885 funds tracked by Wall St. Rank held Biogen as of Q4 2014.

Based on Pacific Alternative Asset Management Company (PAAMCO)'s 13F filing for Q4 2014, filed 13 Feb 2015.